MedaPhor floats on AIM
MedaPhor, the Cardiff-based global provider of advanced ultrasound education and training for medical professionals, has raised £4.7 million in its flotation on the AIM market of the London Stock Exchange to facilitate its ambitious growth plans.
MedaPhor Group plc (“MedaPhor”), the global provider of advanced ultrasound education and training for medical professionals, is pleased to announce that it has raised £4.7 million in its planned flotation on the AIM market of the London Stock Exchange.
MedaPhor’s lead product is ScanTrainer, a virtual reality based ‘real feel’ ultrasound training simulator that enables trainees, of any level, to literally feel what they see on the computer screen in order to develop the complex mix of cognitive skills and eye-hand movement coordination required to learn all the key ultrasound scanning skills. MedaPhor, a Cardiff University spin-out company, is based in Cardiff in the UK and San Diego in the USA. The simulator uses real patient scans, within an educationally driven training programme, to teach the core and advanced ultrasound scanning skills without the need for an ultrasound machine or a patient and with considerably reduced expert supervision.